NM_000251.3(MSH2):c.1825G>T (p.Ala609Ser) AND MSH2-related disorder
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Nov 16, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004532776.1
Allele description [Variation Report for NM_000251.3(MSH2):c.1825G>T (p.Ala609Ser)]
NM_000251.3(MSH2):c.1825G>T (p.Ala609Ser)
Condition(s)
- Name:
- MSH2-related disorder
- Identifiers:
-
Homo sapiens CD320 molecule, mRNA (cDNA clone MGC:828 IMAGE:3347569), complete c...
Homo sapiens CD320 molecule, mRNA (cDNA clone MGC:828 IMAGE:3347569), complete cdsgi|34784777|gb|BC000668.2|Nucleotide
-
Homo sapiens defensin beta 125 (DEFB125) mRNA, complete cds
Homo sapiens defensin beta 125 (DEFB125) mRNA, complete cdsgi|22252924|gb|AY122477.1|Nucleotide
-
rhophilin-1 isoform X3 [Homo sapiens]
rhophilin-1 isoform X3 [Homo sapiens]gi|2462617620|ref|XP_054215678.1|Protein
-
PREDICTED: Homo sapiens rhophilin Rho GTPase binding protein 1 (RHPN1), transcri...
PREDICTED: Homo sapiens rhophilin Rho GTPase binding protein 1 (RHPN1), transcript variant X4, mRNAgi|2462617621|ref|XM_054359704.1|Nucleotide
-
Sequence 1486 from Patent EP1308459
Sequence 1486 from Patent EP1308459gi|32132349|emb|AX747961.1||pat|EP| 59|1486Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 3, 2024